Clayton Associates announced that Larry Kloess has been named Chairman of the firm. This follows the recent announcement that the firm’s co-founder, Stuart McWhorter, will leave his day-to-day role as president and chairman of Clayton Associates to become CEO of the Nashville Entrepreneur Center.
Read MoreVentas announced today that it has signed a definitive agreement to acquire privately-owned Ardent Medical Services, Inc. (with its affiliates “Ardent Health Services”), a premier provider of health care services and one of the ten largest for-profit hospital companies in the U.S., for $1.75 billion in cash. The transaction is expected to be immediately accretive to Ventas’s normalized funds from operations (“FFO”) per share by $0.08 to $0.10 in the first full year after close.
Read MoreJohn R. Ingram, Chairman of the Board of Directors of The Nashville Entrepreneur Center, said today Stuart McWhorter, Chairman and Co-Founder of Clayton Associates, will be the EC's new President & CEO, effective April 9.
The announcement follows a months-long national search, Mr. Ingram said. He commended the board's Search Committee for its thorough process of understanding the leadership qualities the EC will need in the years ahead.
Read MoreJourneyPure, Inc., a provider of addiction treatment services, announced the completion of its Series A Investment Round led by Rolling Hills Ventures, the angel investment fund of Brentwood-based Clayton Associates.
Through a network of inpatient and outpatient facilities located in Tennessee and Florida, JourneyPure offers addiction treatment services with an emphasis on solving co-occurring mental health and substance abuse illnesses. JourneyPure provides patients with services along a full continuum of care that includes detoxification, partial hospitalization programming, intensive outpatient programming, individual therapy, and coaching treatments.
Read MoreClinical Ink, the pioneering provider of eSource solutions for clinical trials, today announced a merger with CentrosHealth, the ground-breaking provider of configurable mobile apps for clinical trial patient engagement and electronic patient reported outcomes (ePRO) founded by MPM Capital. The company also announced that MPM Capital and F2 Ventures joined FCA Venture Partners and other existing investors to provide additional growth capital for Clinical Ink to aggressively expand operational capabilities and further development of the first truly paperless clinical trial platform. Clinical Ink additionally entered into a strategic partnership with Novartis Pharmaceuticals, as part of their Trials of the Future initiative, to help drive industry-wide adoption of fully electronic clinical trials.
Read MoreThe Wistar Institute, an international leader in biomedical research, and Kerafast Inc., developers of an online platform that facilitates accessibility to unique bioresearch materials from laboratories across the globe, today announced Wistar’s partnership in the Kerafast Fellows Program. The program aims to provide scientists with real-life experiences in the technology commercialization field, an exciting, dynamic and increasingly competitive discipline.
Read MoreAn increasing number of healthcare companies are being fined for hiring people on U.S. government exclusion lists as HHS' Office of Inspector General steps up its monitoring of hiring.
Fines totaling $9 million were levied in 2014 against 75 healthcare companies, according to ProviderTrust, a company that offers exclusion list monitoring software and services. That's up from 2013's $3.5 million in fines that hit 45 companies.
MedAssets announced a strategic partnership with Procured Health to deliver a holistic approach to implementing best-practice clinical value analysis programs. Under terms of the agreement, MedAssets will augment its industry-leading clinical value analysis consulting and services with Procured Health's proprietary data intelligence and collaboration technology platform.
Read More